Earnings Scoreboard: 84% of S&P 500 reporting firms top EPS estimates as 72% post Y/Y profit growth
at seekingalpha.com (Sat, 1-Aug 12:30 PM)
Gilead’s Twice-Yearly HIV Strategy: What the New Phase 3 Study Means for Investors
at www.tipranks.com (Thu, 30-Jul 12:32 PM)
at www.tipranks.com (Wed, 29-Jul 1:10 PM)
at www.tipranks.com (Wed, 29-Jul 8:07 AM)
Atea drops despite late-stage trial win for hepatitis C therapy
at seekingalpha.com (Tue, 28-Jul 11:50 AM)
